We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
MHRA reclassifies Nasonex Allergy Control
MHRA reclassifies Otrivine Extra Dual Relief Nasal Spray Solution
After a public consultation, Maloff Protect will now be available over the counter in pharmacies
Maloff Protect anti-malarial tablets will shortly be available to buy from pharmacies, after previously only being available to purchase with a prescription.
MHRA updates guidance for healthcare professionals.
Professor Sir Michael Rawlins, MHRA chair, honoured in the 2017 Queen's Birthday Honours List.
A new e-learning module on the importance of reporting suspected side effects to medicines has received European accreditation.
People and organisations should check public access defibrillators for a technical fault, the Medicines and Healthcare products Regulatory Agency advised today.
From 10 April, we are removing .gsi from our email addresses.
Paying for medicines licences, clinical trials and clinical investigations is changing from 1 April the Medicines and Healthcare products Regulatory Agency (MHRA) announced.
A husband and wife from Bootle have today been sentenced at Liverpool Crown Court for the illegal online sale of unlicensed slimming pills.
Online retailers must follow UK law, as well as the law of the country to which they are selling medicines
The Medicines and Healthcare products Regulatory Agency has launched its latest guide of UK pharmaceutical regulations, EU directives and guidance.
The UK Stem Cell Bank (UKSCB) at the National Institute for Biological Standards and Control (NIBSC) is releasing its first stem cell lines suitable for development into novel cell-based medicines to researchers wishing to b…
MHRA has launched an official blog providing expert insight into the latest regulatory thinking and all aspects of medicines regulation.
Investigation by the Medicines and Healthcare products Regulatory Agency (MHRA) results in guilty pleas for supplying unlicensed, and potentially dangerous, medicinal products.
New Years warning issued urging athletes to avoid potentially dangerous DMAA, otherwise known as Methylhexanamine
MHRA has launched a ‘Week of Action’ to improve awareness of unlicensed medicines containing the potentially dangerous ingredient DMAA.
The quality of biological medicines is assured by biological standards held by the British Pharmacopoeia (BP) and the National Institute for Biological Standards and Control (NIBSC)
In a New Year with new beginnings, the dangers of fake and unlicensed medical products remain the same. We continue our campaign against fake and unlicensed medical products in 2017.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).